Cosibelimab (Anti-B7-H1 / PD-L1 / CD274)
Cosibelimab (Anti-B7-H1 / PD-L1 / CD274) (A2811-GRP)
Products
Description
Cosibelimab (Anti-B7-H1 / PD-L1 / CD274) is an immunoglobulin G1 (IgG1), human monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.64 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2811 |
| Target | PD-1/PD-L1 |